Home Applications 125472 Application 125472
Type BLA
Sponsor GENENTECH Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125472 Actemra tocilizumab 351(a) Rx 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ACTEMRA TOCILIZUMAB INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 162MG/0.9ML No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 30 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-138 Actemra tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current 50242-143 Actemra ACTPen tocilizumab Genentech, Inc. BLA Current